Blistering in systemic lupus erythematosus has been divided into three
groups.(1) A specific subgroup of bullous systemic lupus erythematosu
s' has been defined by Gammon et al. on the basis of a number of crite
ria.(2) From our experience of seven patients with bullous systemic lu
pus erythematosus, and after reviewing the literature, we suggest that
the current classification is too narrow, Our patients displayed clin
ical and immunohistological (based on direct and indirect immunofluore
scence and Western immunoblotting) heterogeneity, Sera from two patien
ts bound to epidermal epitopes in sodium chloride-split skin, but immu
noblotting was negative, In neither of these patients could the target
antigen be type VII collagen, the only antigen identified as pathogen
ic in this disease. Patients with epidermal binding should not be excl
uded from a diagnosis of bullous systemic lupus erythematosus. SLE is
a disease in which there is a genetic predisposition to form antibodie
s to type VII collagen, along with other autoantibodies, many of which
may be implicated in blistering. We suggest that the criteria for the
diagnosis of BSLE should be revised. We define this disease as an acq
uired subepidermal blistering disease in a patient with SLE, in which
immune reactants are present at the basement membrane zone on either d
irect or indirect immunofluorescence.